Cryo-Cell International, Inc. Quarterly report pursuant to Section 13 or 15(d)

Quarterly report pursuant to Section 13 or 15(d)

Stockholders' Equity (Tables)

Stockholders' Equity (Tables) - Service-Based Vesting Condition Options [Member]

3 Months Ended

Feb. 28, 2021

Variables used to determine the fair value of the options granted for the three months ended February 29, 2020 are as follows:

		Three months ended February 29, 2020
Weighted average values:
Expected dividends		0%
Expected volatility		64.25%
Risk free interest rate		1.90%
Expected life		9.0 years

Stock Option Activity

Stock option activity for the three months ended February 28, 2021, was as follows:

				Weighted		Weighted Average
				Average		Remaining		Aggregate
	Options			Exercise Price		Contractual Life (Years)		Intrinsic Value
Outstanding at November 30, 2020		1,174,943		$	3.72		3.42	$	4,502,324
Granted		—			—				—
Exercised		(25,300	)		7.57				—
Expired/forfeited		—			—				—
Outstanding at February 28, 2021		1,149,643		$	3.64		3.08	$	7,315,667
Exercisable at February 28, 2021		1,079,983		$	3.36		2.78	$	7,167,172

Significant Option Groups Exercisable Option and its Price and Contractual Life

Significant option groups exercisable at February 28, 2021 and related price and contractual life information are as follows:

	Outstanding						Exercisable
			Weighted Average		Weighted				Weighted
			Remaining		Average				Average
Range of Exercise Prices	Outstanding		Contractual Life (Years)		Exercise Price		Outstanding		Exercise Price
$1.01 to $2.00		422,500		.85	$	1.73		422,500	$	1.73
$2.01 to $3.00		245,000		.86	$	2.78		245,000	$	2.78
$3.01 to $4.00		204,729		4.99	$	3.14		204,729	$	3.14
$6.01 to $7.00		3,833		5.35	$	6.52		3,388	$	6.51
$7.01 to $8.00		266,581		7.06	$	7.64		203,666	$	7.61
$9.01 to $10.00		7,000		6.45	$	9.10		700	$	9.10
		1,149,643		3.08	$	3.64		1,079,983	$	3.36

Summary of Non-Vested Options

A summary of the status of the Company’s non-vested options as of February 28, 2021, and changes during the three months ended February 28, 2021, is presented below:

				Weighted Average
				Grant-Date
	Options			Fair Value
Non-vested at November 30, 2020		93,380		$	4.65
Granted		—			—
Vested		(23,720	)		4.99
Forfeited		—			—
Non-vested at February 28, 2021		69,660		$	4.53